IVEVF Inventiva S.A.

NEUTRAL Impact: 3/10 6-K
Horizon weeks Filed Jun 9, 2026 Processed 5d 13h ago SEC 0001171843-26-004003
Notable filing: 6-K

Price Chart

Loading chart...

Executive Summary

Inventiva S.A. filed a 6-K announcing the availability of preparatory documents for its Combined General Meeting on June 30, 2026. The meeting includes a 39th resolution related to the EIB Transactions, involving a €50 million repurchase of EIB warrants and issuance of new warrants, subject to shareholder approval. This is a routine procedural filing with no new material financial or operational data.

Actionable Insight

This is a procedural filing with no immediate trading catalyst. Monitor the shareholder vote on June 30, 2026, as approval of the EIB Transactions could reduce warrant overhang and simplify the capital structure. The recent $120 million equity offering (June 2, 2026) and ongoing NATiV3 trial remain the primary drivers.

Key Facts

  • Combined General Meeting scheduled for June 30, 2026 at 2 p.m. in Paris.
  • Agenda includes a 39th resolution regarding the EIB Transactions: repurchase and cancellation of EIB Tranche A Warrants and a portion of Tranche B Warrants for an aggregate repurchase price of €50 million.
  • New EIB Warrants will be issued on more standard terms in substitution for remaining Tranche B Warrants, subject to shareholder approval.
  • Ceilings for resolutions 33-35 (free share grants, stock options, subscription warrants) have been adjusted.
  • Preparatory documents are available on the company's website and at its registered office.

Financial Impact

€50 million aggregate repurchase price for EIB warrants, but no new financial data or operational results disclosed in this filing.

dilutiondebt

Risk Factors

  • Shareholder approval of the EIB Transactions is not guaranteed; failure could delay warrant restructuring.
  • The company remains a clinical-stage biotech with no approved products and significant cash burn.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-004003
Document: f6k_060926.htm0001171843-26-004003
Document: 0001171843-26-004003-index-headers.html0001171843-26-004003
Document: 0001171843-26-004003-index.html0001171843-26-004003
Document: 0001171843-26-004003.txt0001171843-26-004003
7 reports for IVEVF
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+20▲ +3.09%Apr 8, 2026
Filters
Rows
Reports for IVEVF — sortable, filterable
Type Now
Jun 9, 2026
5d ago
6-K
NEUTRAL ★ 3/10
$5.33 awaiting T+1awaiting T+1$5.33 (−0.00%)
Jun 3, 2026
11d ago
6-K
NEUTRAL ★ 2/10
$5.33 $5.33· 0.00%▼ −0.40%$5.33 (−0.00%)
Jun 3, 2026
12d ago
6-K
BULLISH ★ 7/10
$5.33 $5.33· 0.00%▼ −0.40%$5.33 (−0.00%)
May 26, 2026
19d ago
6-K
NEUTRAL ★ 4/10
$5.33 $5.33· 0.00%▼ −0.55%$5.33 (−0.00%)
May 22, 2026
23d ago
6-K
BEARISH ★ 6/10
$5.33 $5.33· 0.00%▲ +0.01%$5.33 (+0.00%)
Apr 8, 2026
9w ago
20-F
BEARISH ★ 6/10
$5.50 $5.50· 0.00%▲ +0.57%$5.33 (+3.09%)
Mar 30, 2026
10w ago
6-K
MIXED ★ 6/10
$5.50 $5.50· 0.00%▼ −0.75%$5.33 (−3.09%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access